Miochol-E (Acetylcholine Chloride)

Acetylcholine chloride, the active ingredient in Miochol-E, is a cholinergic agonist presented as eye drops for intraocular use. It induces miosis for diagnostic and surgical procedures and helps lower intra‑ocular pressure in glaucoma patients. GNH USA supplies Miochol-E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Miochol‑E acts on the ocular muscarinic pathway to produce controlled pupil constriction and facilitate fluid dynamics. - Diagnostic ophthalmic procedures: provides reliable miosis to improve examination accuracy. - Surgical ophthalmology: induces pupil constriction to enhance intra‑ocular surgical field visibility. - Glaucoma adjunctive therapy: lowers intra‑ocular pressure by improving aqueous humor outflow.

Miochol‑E may cause ocular and systemic reactions.

Common Side Effects: - Transient blurred vision: temporary loss of visual clarity after instillation. - Eye irritation or burning: mild discomfort at the application site. - Excessive tearing: increased lacrimation following dosing. - Conjunctival redness: mild hyperemia of the eye. - Headache: occasional mild headache after use. - Mild ocular pain: brief discomfort in the treated eye.

Serious or Rare Side Effects: - Severe ocular inflammation: uveitis or iritis requiring immediate attention. - Allergic reaction: swelling, rash, or hives around the eye. - Systemic cholinergic effects: bradycardia, hypotension, or bronchospasm. - Persistent miosis: prolonged pupil constriction affecting vision. - Corneal edema: swelling of the cornea that may impair vision. - Vision loss: rare but serious loss of visual acuity.

Before using Miochol‑E, consider the following safety measures. - Contraindication assessment: avoid in patients with narrow‑angle glaucoma or known hypersensitivity. - Intra‑ocular pressure monitoring: check pressure before and after administration. - Caution with systemic cholinergic drugs: assess for additive effects. - Avoid use in patients on anticholinergic therapy that may diminish efficacy. - Educate patients on signs of serious adverse reactions. - Store at room temperature: keep in the original container, protect from light and moisture.

Miochol‑E can interact with other agents affecting cholinergic pathways.

Major Interactions (Avoid): - Systemic cholinesterase inhibitors: may cause excessive cholinergic stimulation. - Other muscarinic agonists: additive ocular constriction and systemic effects.

Moderate Interactions (Monitor Closely): - Anticholinergic medications: may reduce therapeutic response. - Beta‑blocker eye drops: potential additive intra‑ocular pressure reduction. - Systemic antihistamines: possible interference with ocular response.